Benitec Biopharma Inc. Entity Listing, Par Value Per Share
Benitec Biopharma Inc. (BNTC) reported Entity Listing, Par Value Per Share of $0.00 per share for the 12-month period ending 2020-06-30, per its 10-K filed 2020-09-23.
Discontinued › Notes
dei:EntityListingParValuePerShare · last filed 2020-09-23
- Benitec Biopharma Inc. entity listing, par value per share for fiscal 2020 was $0.00.
| Period end | Entity Listing, Par Value Per Share 12 month |
|---|---|
| 2020-06-30 | $0.00 10-K · filed 2020-09-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |